Home
Una Ørvim Sølvik's picture

Una Ørvim Sølvik

Associate Professor

Affiliated with the research groups SMIL og Arbeid, Helse og Kjønn

 

My main research interests:

  • Laboratorymedisin
  • Diabetes
  • Coagulation - INR
  • Self control anticoagulant treatment
  • Analytical quality control
  • Women's health

Associated with Section for Health Sciences and Teaching group leader for Health and Society

Associated with master in Health and Society and Masters in Health Science. 

Associated with Program selection for master's in health sciences, IGS, UiB

Emneansvarlig i emnene Forskningsmetode (HELSAM303) og Kvantitative forskningsmetodar og tradisjonar (HELSAM305)

Koordinator for Masterprogram i helsevitenskap, studieretning for radiografer og bioingeniører

Academic article
  • Show author(s) (2021). Type 2-diabetes i fastlegepraksis – en fokusgruppestudie. Tidsskrift for Den norske legeforening. 1-9.
  • Show author(s) (2020). Pharmacists’ experience of a diabetes risk-assessment service and analytical quality control in community pharmacies – A focus-group study. Research in Social and Administrative Pharmacy. 1259-1266.
  • Show author(s) (2020). Performance and user-friendliness of the rapid antigen detection tests QuickVue Dipstick Strep A test and DIAQUICK Strep A Blue Dipstick for pharyngotonsillitis caused by Streptococcus pyogenes in primary health care. European Journal of Clinical Microbiology and Infectious Diseases. 549-558.
  • Show author(s) (2019). Quality of warfarin therapy and quality of life are improved by self-management for two years. Thrombosis and Haemostasis. 1632-1641.
  • Show author(s) (2019). Commutability of a whole-blood external quality assessment material for point-of-care C-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 791-797.
  • Show author(s) (2018). The EuBIVAS: Within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clinical Chemistry. 1380-1393.
  • Show author(s) (2018). Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes ? A feasibility study. PLOS ONE. 1-13.
  • Show author(s) (2018). Quality control of Norwegian pharmacy HbA1c testing: a modest beginning. Journal of Diabetes Science and Technology. 753-761.
  • Show author(s) (2017). The EuBIVAS project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring. Clinical Chemistry. 1527-1536.
  • Show author(s) (2017). Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. Clinical Chemistry and Laboratory Medicine. 1857-1864.
  • Show author(s) (2017). Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum. Clinical Chemistry. 1141-1150.
  • Show author(s) (2016). The potential for deprescribing in care home residents with Type 2 diabetes. International Journal of Clinical Pharmacy. 977-984.
  • Show author(s) (2016). Sample collections from healthy volunteers for biological variation estimates' update: A new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clinical Chemistry and Laboratory Medicine. 1599-1608.
  • Show author(s) (2016). 'I try not to bother the residents too much' - the use of capillary blood glucose measurements in nursing homes. BMC Nursing.
  • Show author(s) (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 849-853.
  • Show author(s) (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
  • Show author(s) (2014). Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control. Diabetes Research and Clinical Practice. 102-109.
  • Show author(s) (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
  • Show author(s) (2013). Diagnosing Diabetes Mellitus: Performance of Hemoglobin A(1c) Point-of-Care Instruments in General Practice Offices. Clinical Chemistry. 1790-1801.
  • Show author(s) (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
  • Show author(s) (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 1618-1626.
  • Show author(s) (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
  • Show author(s) (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
  • Show author(s) (2006). External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-350.
  • Show author(s) (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-349.
Reader opinion piece
  • Show author(s) (2007). Response to Kitchen et al.'s external quality assessment of prothrombin time: The split-sample model compared to external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 676-677.
Masters thesis
  • Show author(s) (2013). Rolleutvidelse ved noen bildediagnostiske avdelinger i Norge.
  • Show author(s) (2013). PGMI klassifisering av mammografibilder ved interne og eksterne mamma-radiografer.
  • Show author(s) (2013). Er laboratorierutiner og laboratoriekvalitet ved norske sykehjem endret? Har opplæring og oppfølging initiert av Noklus som del av Omsorgsplan 2015 nyttet?
  • Show author(s) (2012). Sammenligning av nukleinsyre isoleringsteknikker i forbindelse med etablering av qPCR påvisningsmetode for Borrelia infeksjon.
  • Show author(s) (2011). Videreutdanning i Ultralyd for radiografer I hvilken grad er læringsmålene nådd? En kontrollert prospektiv sammenlignende studie 6 mnd etter endt utdanning.
  • Show author(s) (2011). Trygg antikoagulasjonsbehandling: Pasienter i Norge kan drive egenkontroll av warfarinbehandling.
  • Show author(s) (2011). Tredimensjonale ultralyd volummålinger IN VITRO validering av metode til oppfølging av abdominale aortaaneurismer.
  • Show author(s) (2011). Strålebehandling til kvinner med brystkreft Endring av venstre ventrikkels ejeksjonsfraksjon (LVEF) gjennom et behandlingsforløp med strålebehandling, målt med den nukleærmedisinske metoden planar MUGA- scan.
  • Show author(s) (2011). Bildeveiledet stråleterapiVil bruk av konvensjonell stimulator bidra til å minimere systematiske innstillingsavvik, og dermed øke innstillingspresisjonen, sammenlignet med bildeveiledet innstilling på behandlingsapparat?
  • Show author(s) (2010). Utfordringer ved digital bildeteknologi; en kvalitativ studie av radiografers rolle og deres oppfatning av bildekvalitet ved arbeid med digitale røntgenbilder.
  • Show author(s) (2010). Hvordan lav og høy temperatur påvirker måling av blodsukker med apparater i bruk av personer med diabetes.
  • Show author(s) (2010). Feltstyrke ved Magnetisk Resonansskanning af håndled og fingrenes led hos pasienter med leddegigt.
  • Show author(s) (2010). Deteksjon av tidlige veggforandringer i halsarterier hos barn og unge med type-1 diabetes.
  • Show author(s) (2010). Betydning av pasientleie for tynntarmsdose ved strålebehandling av pasienter med rectumcancer.
  • Show author(s) (2010). Betydning av behandlingsleie for reproduserbarhet ved strålebehandling av rectumcancer.
  • Show author(s) (2009). Strålebehandling av pasienter med brystkreft og bruk av intensitetsmodulert radioterapi (IMRT).
  • Show author(s) (2009). Processerings optimering med Canons software -et fantom projekt om dosis besparelse ved anvendelse af Canons nye DR Spectra software på børnefemur undersøgelser.
  • Show author(s) (2007). Analyse av protrombintid i primærhelsetjenesten - vurdering av analysekvalitet og en evaluering av to kontrollsystem for analytisk kvalitetskontroll ved hjelp av datasimuleringer.
Letter to the editor
  • Show author(s) (2018). Hemolysis interference studies: Freeze method should be used in the preparation of hemolyzed samples. Clinical Chemistry and Laboratory Medicine. 1-3.
  • Show author(s) (2017). Effect of dabigatran treatment at therapeutic levels on point-of-care international normalized ratio (INR). Clinical Chemistry and Laboratory Medicine. e143-e145.
  • Show author(s) (2015). Performance of 10 systems for self-monitoring of blood glucose by trained healthcare professionals and in the hands of the users. Clinical Chemistry. 772-774.
Doctoral dissertation
  • Show author(s) (2019). Diabetes in care homes. Special emphasis on medicines and blood glucose measurements.
Abstract
  • Show author(s) (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
Poster
  • Show author(s) (2016). ‘It’s a jungle out there’ - A focus group study about being diagnosed with type 2 diabetes.
  • Show author(s) (2016). A feasibility study for risk assessment ofType 2 Diabetes (T2D) in pharmacies.

More information in national current research information system (CRIStin)